Investigating the Impact of NMDA Receptor Organization and Biological Sex in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2025 Feb 26

PMID 40004200

Authors

Senka Hadzibegovic

Bruno Bontempi

Olivier Nicole

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory loss and cognitive decline, with women being disproportionately affected in both prevalence and severity. A key feature of AD is synaptic loss, particularly around amyloid-β (Aβ) aggregates, which correlates strongly with the severity of dementia. Oligomeric Aβ is believed to be the primary driver of synaptic dysfunction by impairing excitatory neurotransmission through interactions with synaptic receptors, including N-methyl-D-aspartate (NMDA) receptors. However, the influence of sex on these synaptic changes and NMDA receptor mislocalization in AD is not well understood. This study examined potential sex-specific differences in synaptotoxicity and the role of extrasynaptic GluN2B-containing NMDA receptors in AD pathogenesis using the APP/PS1 double transgenic mouse model. Although both male and female mice showed a similar amyloid burden and cognitive impairments, synaptic alterations were slightly less severe in females, suggesting subtle sex differences in synaptic pathology. Both sexes exhibited the mislocalization of GluN2B subunits to extrasynaptic areas, which was linked to reduced PSD-95 levels and the synaptic accumulation of Aβ. Intrahippocampal injections of DL-TBOA confirmed the role of extrasynaptic GluN2B-containing NMDA receptors in memory dysfunction. These findings emphasize the importance of targeting synaptic receptor trafficking to address AD-related memory deficits, potentially offering a therapeutic approach for both sexes.

References

Hirata-Fukae C, Li H, Hoe H, Gray A, Minami S, Hamada K . Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res. 2008; 1216:92-103. DOI: 10.1016/j.brainres.2008.03.079. View

Malinow R . New developments on the role of NMDA receptors in Alzheimer's disease. Curr Opin Neurobiol. 2011; 22(3):559-63. PMC: 3405538. DOI: 10.1016/j.conb.2011.09.001. View

Han J, Kesner P, Metna-Laurent M, Duan T, Xu L, Georges F . Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell. 2012; 148(5):1039-50. DOI: 10.1016/j.cell.2012.01.037. View

Escamilla S, Badillos R, Comella J, Sole M, Perez-Otano I, Mut J . Synaptic and extrasynaptic distribution of NMDA receptors in the cortex of Alzheimer's disease patients. Alzheimers Dement. 2024; 20(12):8231-8245. PMC: 11667538. DOI: 10.1002/alz.14125. View

Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30(4):572-80. DOI: 10.1002/ana.410300410. View

Hardingham G, Bading H . Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci. 2010; 11(10):682-96. PMC: 2948541. DOI: 10.1038/nrn2911. View

Ferretti M, Iulita M, Cavedo E, Chiesa P, Dimech A, Chadha A . Sex differences in Alzheimer disease - the gateway to precision medicine. Nat Rev Neurol. 2018; 14(8):457-469. DOI: 10.1038/s41582-018-0032-9. View

Diociaiuti M, Bonanni R, Cariati I, Frank C, DArcangelo G . Amyloid Prefibrillar Oligomers: The Surprising Commonalities in Their Structure and Activity. Int J Mol Sci. 2021; 22(12). PMC: 8235680. DOI: 10.3390/ijms22126435. View

Wang R, Reddy P . Role of Glutamate and NMDA Receptors in Alzheimer's Disease. J Alzheimers Dis. 2016; 57(4):1041-1048. PMC: 5791143. DOI: 10.3233/JAD-160763. View

10.

Marshall C, McBride J, Changolkar L, Riddle D, Trojanowski J, Lee V . Inhibition of CK2 mitigates Alzheimer's tau pathology by preventing NR2B synaptic mislocalization. Acta Neuropathol Commun. 2022; 10(1):30. PMC: 8895919. DOI: 10.1186/s40478-022-01331-w. View

11.

Zhao W, Santini F, Breese R, Ross D, Zhang X, Stone D . Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption. J Biol Chem. 2009; 285(10):7619-32. PMC: 2844209. DOI: 10.1074/jbc.M109.057182. View

12.

Lavezzari G, McCallum J, Dewey C, Roche K . Subunit-specific regulation of NMDA receptor endocytosis. J Neurosci. 2004; 24(28):6383-91. PMC: 6729547. DOI: 10.1523/JNEUROSCI.1890-04.2004. View

13.

Hardingham G . NMDA receptor C-terminal signaling in development, plasticity, and disease. F1000Res. 2019; 8. PMC: 6720038. DOI: 10.12688/f1000research.19925.1. View

14.

Lee M, Yasuda R, Ehlers M . Metaplasticity at single glutamatergic synapses. Neuron. 2010; 66(6):859-70. PMC: 2911980. DOI: 10.1016/j.neuron.2010.05.015. View

15.

Li S, Jin M, Koeglsperger T, Shepardson N, Shankar G, Selkoe D . Soluble Aβ oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors. J Neurosci. 2011; 31(18):6627-38. PMC: 3100898. DOI: 10.1523/JNEUROSCI.0203-11.2011. View

16.

Rushworth J, Hooper N . Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes. Int J Alzheimers Dis. 2011; 2011:603052. PMC: 3014710. DOI: 10.4061/2011/603052. View

17.

Hsu C, Hsieh Y, Lue S, Hsu H . Sex-specific expression of N-methyl D-aspartate receptor (NMDAR) in the preoptic area of neonatal rats. Neurosci Lett. 1999; 262(2):85-8. DOI: 10.1016/s0304-3940(99)00038-5. View

18.

Dore K, Carrico Z, Alfonso S, Marino M, Koymans K, Kessels H . PSD-95 protects synapses from β-amyloid. Cell Rep. 2021; 35(9):109194. PMC: 8237704. DOI: 10.1016/j.celrep.2021.109194. View

19.

Bading H . Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations. J Exp Med. 2017; 214(3):569-578. PMC: 5339681. DOI: 10.1084/jem.20161673. View

20.

Renner M, Lacor P, Velasco P, Xu J, Contractor A, Klein W . Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron. 2010; 66(5):739-54. PMC: 3111138. DOI: 10.1016/j.neuron.2010.04.029. View